1 month ago
On September 15, Digital Realty (NYSE:DLR) made ServiceFabric MCP available, a software layer that lets AI agents design, monitor and troubleshoot network connections across more than 800 data centers, including third-party sites. That nudges a real estate company toward becoming a control panel for enterprise AI. It arrives after second quarter results reported on July 23, when Core FFO per share, the company's preferred earnings yardstick, excluding net promote rose to $2.13 from $1.87 a year earlier. Here is what the launch does, and what it has yet to prove.
The pitch is that enterprise AI needs more than servers. It needs power, cooling, and sovereign placement that software can control. ServiceFabric MCP handles four jobs: designing and provisioning connections, spotting capacity and watching live network health, managing access through OAuth 2, and handing troubleshooting to agents with links into chat and monitoring tools. It is also open by design. Customers do not have to live only in Digital Realty buildings or commit to a single AI model. An IDC research VP argues that public cloud interfaces alone cannot give enterprises enough control over data movement and policy, which favors providers that pair global reach with programmable interconnection. Digital Realty runs the system on its own AI workloads, and See All AI, a medical imaging developer, leans on the Boston campus and ServiceFabric to move large datasets quickly and securely.
The financial engine underneath is running hot. Renewal leases in the second quarter were signed at rates 25.4% higher on a cash basis, which shows customers will pay more to stay put. Signed leases waiting to start added up to a $1.9 billion backlog of annualized base rent at 100% share, so future revenue is already lined up. Management responded by lifting its 2026 Core FFO per share outlook, excluding net promote, to $8.15 to $8.20.
Start with what the launch has not shown yet. Digital Realty itself calls MCP an emerging standard, and ServiceFabric MCP is still being validated across internal, enterprise, and partner deployments. The announcement puts no dollar figure on what it could add to revenue, and the company describes it only as the first programmable surface of a larger architecture that may later stretch into ***** e, power and inventory. Until customers pay for this layer, it is a promising idea more than a line item.
Then there is the bill for the physical side. Digital Realty carried about $18.6 billion of debt at June 30, 2026, and its 2026 development spending outlook, net of partner contributions, now sits at $4.25 billion to $4.75 billion. The outlook also ***** umes new long-term debt priced at 4.5% to 5.5%, up from the earlier 4.0% to 4.5%. To help pay for growth, the company has sold roughly 13.5 million shares this year for about $2.5 billion, which spreads future earnings across more owners. And the quarter's headline flattered a bit: Core FFO per share of $2.65 included a $18
The pitch is that enterprise AI needs more than servers. It needs power, cooling, and sovereign placement that software can control. ServiceFabric MCP handles four jobs: designing and provisioning connections, spotting capacity and watching live network health, managing access through OAuth 2, and handing troubleshooting to agents with links into chat and monitoring tools. It is also open by design. Customers do not have to live only in Digital Realty buildings or commit to a single AI model. An IDC research VP argues that public cloud interfaces alone cannot give enterprises enough control over data movement and policy, which favors providers that pair global reach with programmable interconnection. Digital Realty runs the system on its own AI workloads, and See All AI, a medical imaging developer, leans on the Boston campus and ServiceFabric to move large datasets quickly and securely.
The financial engine underneath is running hot. Renewal leases in the second quarter were signed at rates 25.4% higher on a cash basis, which shows customers will pay more to stay put. Signed leases waiting to start added up to a $1.9 billion backlog of annualized base rent at 100% share, so future revenue is already lined up. Management responded by lifting its 2026 Core FFO per share outlook, excluding net promote, to $8.15 to $8.20.
Start with what the launch has not shown yet. Digital Realty itself calls MCP an emerging standard, and ServiceFabric MCP is still being validated across internal, enterprise, and partner deployments. The announcement puts no dollar figure on what it could add to revenue, and the company describes it only as the first programmable surface of a larger architecture that may later stretch into ***** e, power and inventory. Until customers pay for this layer, it is a promising idea more than a line item.
Then there is the bill for the physical side. Digital Realty carried about $18.6 billion of debt at June 30, 2026, and its 2026 development spending outlook, net of partner contributions, now sits at $4.25 billion to $4.75 billion. The outlook also ***** umes new long-term debt priced at 4.5% to 5.5%, up from the earlier 4.0% to 4.5%. To help pay for growth, the company has sold roughly 13.5 million shares this year for about $2.5 billion, which spreads future earnings across more owners. And the quarter's headline flattered a bit: Core FFO per share of $2.65 included a $18
1 month ago
Prosper Stars & Stripes, a long/short equity fund, recently released its second-quarter 2026 investor letter. The letter can be downloaded here. In Q2 2026, the portfolio delivered a strong net return of +30.1% compared to the Russell 2000 Index's +21.5% return and the HFRX Equity Hedge Index's +10.3% return. The long book drove performance, generating a 43.2% gross contribution, while average net exposure remained relatively modest at 47%. U.S. economic growth remained resilient despite inflation concerns, elevated energy prices, and geopolitical uncertainty. Markets rallied sharply after easing U.S.-Iran tensions pushed oil prices lower, supporting renewed risk appetite. Small-cap equities benefited significantly, with Information Technology, Industrials, and Health Care leading gains, while Energy declined as crude prices fell. Year to date, the Composite returned +23.7%, slightly ahead of the Russell 2000's +22.6% and well above the HFRI Equity Hedge Index's +9.7%. Additionally, you can review the Portfolio's top 5 holdings to see its best picks for 2026.
In its second-quarter 2026 investor letter, Prosper Stars & Stripes highlighted Dolby Laboratories, Inc. (NYSE:DLB). Dolby Laboratories, Inc. (NYSE:DLB) is a US-based technology company that designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries. On September 14, 2026, Dolby Laboratories, Inc. (NYSE:DLB) closed at $61.91 per share. Over the past month, Dolby Laboratories, Inc. (NYSE:DLB) returned 1.33%, and its shares lost 14.24% over the past 52 weeks. Dolby Laboratories, Inc. (NYSE:DLB) has a market capitalization of $5.79 billion, and its stock has traded within a 52-week range of $48.26 and $73.01.
Prosper Stars & Stripes stated the following regarding Dolby Laboratories, Inc. (NYSE:DLB) in its Q2 2026 investor letter:
"This year's market rally has pressured short returns and narrowed the windows to successfully monetize shorts, as we would expect. Certain themes and short ideas do continue to resonate, however. One theme that has had success is the ongoing pressure caused by the investment boom in AI crowding out spending in other areas. We have shorted Universal Display Corp (OLED), Dolby Laboratories, Inc. (NYSE:DLB), and Logitech International (LOGI) on this theme. We believe cost pressures on technology components such as DRAM to result in higher prices for consumer electronics. This would have a significant impact on back-to-school and holiday spending, the key periods for these companies' end markets. We expect the forecasts that these companies are providing at this time of the year to prove optimistic, as tech cost inflation is unusual. Further, we believe the so-called K-shaped economy, where consumers have felt the pressure of rising costs of living, will continue to squeeze discretionary purchases like these. Rising prices make it nearly impossible to use discounts to st
In its second-quarter 2026 investor letter, Prosper Stars & Stripes highlighted Dolby Laboratories, Inc. (NYSE:DLB). Dolby Laboratories, Inc. (NYSE:DLB) is a US-based technology company that designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries. On September 14, 2026, Dolby Laboratories, Inc. (NYSE:DLB) closed at $61.91 per share. Over the past month, Dolby Laboratories, Inc. (NYSE:DLB) returned 1.33%, and its shares lost 14.24% over the past 52 weeks. Dolby Laboratories, Inc. (NYSE:DLB) has a market capitalization of $5.79 billion, and its stock has traded within a 52-week range of $48.26 and $73.01.
Prosper Stars & Stripes stated the following regarding Dolby Laboratories, Inc. (NYSE:DLB) in its Q2 2026 investor letter:
"This year's market rally has pressured short returns and narrowed the windows to successfully monetize shorts, as we would expect. Certain themes and short ideas do continue to resonate, however. One theme that has had success is the ongoing pressure caused by the investment boom in AI crowding out spending in other areas. We have shorted Universal Display Corp (OLED), Dolby Laboratories, Inc. (NYSE:DLB), and Logitech International (LOGI) on this theme. We believe cost pressures on technology components such as DRAM to result in higher prices for consumer electronics. This would have a significant impact on back-to-school and holiday spending, the key periods for these companies' end markets. We expect the forecasts that these companies are providing at this time of the year to prove optimistic, as tech cost inflation is unusual. Further, we believe the so-called K-shaped economy, where consumers have felt the pressure of rising costs of living, will continue to squeeze discretionary purchases like these. Rising prices make it nearly impossible to use discounts to st
1 month ago
OpenAI acquired Glass Imaging, a startup developing AI-powered smartphone camera technology, in a deal valued at over $300 million, according to The Wall Street Journal. The purchase price represents a significant jump from the roughly $100 million valuation Glass Imaging carried in a funding round last year.
Glass Imaging was founded in 2019 by Ziv Attar and Tom Bishop, two former Apple engineers who worked on the company's Portrait Mode feature. The Los Altos, California-based company had raised about $30 million from investors including GV, Alphabet's venture arm, and Insight Partners before the acquisition.
Glass Imaging's approach differs from conventional AI photo editing: instead of processing images after the fact, the company teaches neural networks the specific optical properties of each camera system so that picture quality is improved as the shot is taken, according to The Wall Street Journal. The company's goal is to produce image quality comparable to a DSLR camera from a smartphone. Its zoom-imaging technology was featured in a line of phones from Chinese smartphone brand Honor.
OpenAI's plans for Glass Imaging are unclear. The company is also developing a device with Jony Ive, the former Apple designer behind the iPhone. OpenAI brought on Ive in 2025 through its $6.5 billion purchase of io Products, and his responsibilities span hardware development alongside broader efforts to define how AI products will look and function.
A spokesperson for OpenAI had not provided a statement by the time of publication, according to TechCrunch. The company has made several other acquisitions recently, including an internet talk show called TBPN and an open-source developer tools startup, according to The Wall Street Journal. OpenAI is also preparing for an initial public offering expected next year.
#according #journal
Glass Imaging was founded in 2019 by Ziv Attar and Tom Bishop, two former Apple engineers who worked on the company's Portrait Mode feature. The Los Altos, California-based company had raised about $30 million from investors including GV, Alphabet's venture arm, and Insight Partners before the acquisition.
Glass Imaging's approach differs from conventional AI photo editing: instead of processing images after the fact, the company teaches neural networks the specific optical properties of each camera system so that picture quality is improved as the shot is taken, according to The Wall Street Journal. The company's goal is to produce image quality comparable to a DSLR camera from a smartphone. Its zoom-imaging technology was featured in a line of phones from Chinese smartphone brand Honor.
OpenAI's plans for Glass Imaging are unclear. The company is also developing a device with Jony Ive, the former Apple designer behind the iPhone. OpenAI brought on Ive in 2025 through its $6.5 billion purchase of io Products, and his responsibilities span hardware development alongside broader efforts to define how AI products will look and function.
A spokesperson for OpenAI had not provided a statement by the time of publication, according to TechCrunch. The company has made several other acquisitions recently, including an internet talk show called TBPN and an open-source developer tools startup, according to The Wall Street Journal. OpenAI is also preparing for an initial public offering expected next year.
#according #journal
1 month ago
With the news that Philadelphia Eagles offensive lineman Landon ******* erson was being placed on IR with a knee injury, ******* erson himself seemed fine with the development — especially since, in the guard's view, he had no business being on the field in Week 1.
In an interview on Philadelphia's 94 WIP radio, which took place very shortly after the IR news landed, ******* erson offered a blunt ******* sment of his play in the Eagles' narrow 24-22 win over the Washington Commanders on Sunday.
"Honestly, (to) address the elephant in the room, I played like sh** yesterday," ******* erson said. "I was a complete liability yesterday and, again, that was my fault … I shouldn't be out there until I feel healthy."
Dickerson said that he got "rolled up on" in practice last month during training camp, but continued to push through the injury. Imaging on Monday confirmed that he had a bone bruise in his right knee.
Dickerson found out that he was being placed on IR while live on air: After being read a report from the Philadelphia Inquirer's Jeff McClane, who was the first to report the news, the Eagles' starting left guard admitted to WIP that he hadn't been officially told, but that he knew it "was kind of the plan."
#Eagles #yesterday
In an interview on Philadelphia's 94 WIP radio, which took place very shortly after the IR news landed, ******* erson offered a blunt ******* sment of his play in the Eagles' narrow 24-22 win over the Washington Commanders on Sunday.
"Honestly, (to) address the elephant in the room, I played like sh** yesterday," ******* erson said. "I was a complete liability yesterday and, again, that was my fault … I shouldn't be out there until I feel healthy."
Dickerson said that he got "rolled up on" in practice last month during training camp, but continued to push through the injury. Imaging on Monday confirmed that he had a bone bruise in his right knee.
Dickerson found out that he was being placed on IR while live on air: After being read a report from the Philadelphia Inquirer's Jeff McClane, who was the first to report the news, the Eagles' starting left guard admitted to WIP that he hadn't been officially told, but that he knew it "was kind of the plan."
#Eagles #yesterday
1 month ago
The Eagles will place left guard Landon ***** erson on injured reserve with a knee injury.
Dickerson appeared on WIP's "Players Lounge Show" as news hit that he was headed to IR with what he described as a bone bruise in his right knee.
He said he "played like ***** " in the Eagles' 24-22 win over the Commanders on Sunday.
"I was a complete liability yesterday," ***** erson said, via Alexis Chassen of bleedinggreennation.com. "Again, that was my fault. I know I said earlier in camp I shouldn't be out there until I feel healthy. A few weeks ago, [I] got rolled up on in practice. I thought as weeks went by it would get better. It didn't, and we kind of went out there and finally got some imaging on it today, figured out what was wrong with it.
"Really the best plan going forward is to put me on IR, so I can get this thing better to have a good stretch at the back end of the season versus kind of what happened last year, go out there limping through 18 weeks. I don't think anyone wants to see that again because that was just ugly. I don't want to do that again, because that was just some BS."
#Eagles #knee #kind #players
Dickerson appeared on WIP's "Players Lounge Show" as news hit that he was headed to IR with what he described as a bone bruise in his right knee.
He said he "played like ***** " in the Eagles' 24-22 win over the Commanders on Sunday.
"I was a complete liability yesterday," ***** erson said, via Alexis Chassen of bleedinggreennation.com. "Again, that was my fault. I know I said earlier in camp I shouldn't be out there until I feel healthy. A few weeks ago, [I] got rolled up on in practice. I thought as weeks went by it would get better. It didn't, and we kind of went out there and finally got some imaging on it today, figured out what was wrong with it.
"Really the best plan going forward is to put me on IR, so I can get this thing better to have a good stretch at the back end of the season versus kind of what happened last year, go out there limping through 18 weeks. I don't think anyone wants to see that again because that was just ugly. I don't want to do that again, because that was just some BS."
#Eagles #knee #kind #players
1 month ago
Our ***** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Achieved record quarterly revenue of $24 million, validating the long-term strategy of transitioning toward higher-value integrated systems and custom cabling solutions.
Realized significant operating leverage as revenue surpassed the $20 million threshold, driving adjusted EBITDA margins to 11.1%, exceeding the company's 10% long-term goal.
Diversification efforts successfully reduced reliance on traditional telecom, with meaningful contributions from aerospace, defense, industrial manufacturing, and medical imaging.
Unified engineering and product management teams into a single structure to accelerate product launches and ensure technical innovation translates directly to revenue impact.
#long #product
Achieved record quarterly revenue of $24 million, validating the long-term strategy of transitioning toward higher-value integrated systems and custom cabling solutions.
Realized significant operating leverage as revenue surpassed the $20 million threshold, driving adjusted EBITDA margins to 11.1%, exceeding the company's 10% long-term goal.
Diversification efforts successfully reduced reliance on traditional telecom, with meaningful contributions from aerospace, defense, industrial manufacturing, and medical imaging.
Unified engineering and product management teams into a single structure to accelerate product launches and ensure technical innovation translates directly to revenue impact.
#long #product
2 months ago
American League triple-crown contender Yordan Alvarez is out of the Houston Astros' lineup for Friday due to a sore right ankle.
Alvarez twisted his ankle while running the bases in Thursday's 2-1 win over the Philadelphia Phillies. He went 0-for-3 with 3 strikeouts against Phillies starter Zack Wheeler.
But Alvarez reached base in the eighth inning on an intentional walk from José Alvarado. He advanced to third base on a Jose Altuve double, but stumbled over the bag and was checked out by trainers.
Alvarez stayed in the game, but did not have to run on a Daulton Varsho pop-up. As the designated hitter, he didn't have to take the field in the bottom of the inning.
Astros manager Joe Espada said no imaging was necessary for Alvarez's ankle, according to MLB.com's Brian McTaggart. He did some hitting earlier in the day and could be available to pinch-hit.
#ankle #Phillies #inning
Alvarez twisted his ankle while running the bases in Thursday's 2-1 win over the Philadelphia Phillies. He went 0-for-3 with 3 strikeouts against Phillies starter Zack Wheeler.
But Alvarez reached base in the eighth inning on an intentional walk from José Alvarado. He advanced to third base on a Jose Altuve double, but stumbled over the bag and was checked out by trainers.
Alvarez stayed in the game, but did not have to run on a Daulton Varsho pop-up. As the designated hitter, he didn't have to take the field in the bottom of the inning.
Astros manager Joe Espada said no imaging was necessary for Alvarez's ankle, according to MLB.com's Brian McTaggart. He did some hitting earlier in the day and could be available to pinch-hit.
#ankle #Phillies #inning
2 months ago
IDEXX Laboratories, Inc. (IDXX) is a leading animal-health diagnostics and technology company best known for providing veterinarians with diagnostic testing, laboratory services, software, and imaging solutions. Valued at a market cap of $45.7 billion, the company develops and supplies diagnostic instruments, test kits, software, and laboratory services that help veterinarians, farmers, and laboratories detect diseases and monitor animal health.
Companies worth between $10 billion and $200 billion are typically classified as "large-cap stocks," and IDXX fits the label perfectly. The company is widely recognized as a market leader in veterinary diagnostics, supported by strong brand recognition, a large installed base of diagnostic instruments across veterinary practices, and a recurring revenue model fueled by consumables and testing services. With its solutions used by veterinary practices in more than 175 countries, the company has built a strong global presence and a broad, highly recurring customer base.
'Not Tens Of Billions, But Tens Of Trillions': Nvidia CEO Jensen Huang Says AI Is Like the New Electricity and the Scale Is Unlike Any Tech in History
What It Means for MSFT Stock Investors as Microsoft Switches to 2 Business Segments
RKLB Stock Jumps as Rocket Lab Debuts New Solar Cell for ******* e
#Services #Stock #laboratories
Companies worth between $10 billion and $200 billion are typically classified as "large-cap stocks," and IDXX fits the label perfectly. The company is widely recognized as a market leader in veterinary diagnostics, supported by strong brand recognition, a large installed base of diagnostic instruments across veterinary practices, and a recurring revenue model fueled by consumables and testing services. With its solutions used by veterinary practices in more than 175 countries, the company has built a strong global presence and a broad, highly recurring customer base.
'Not Tens Of Billions, But Tens Of Trillions': Nvidia CEO Jensen Huang Says AI Is Like the New Electricity and the Scale Is Unlike Any Tech in History
What It Means for MSFT Stock Investors as Microsoft Switches to 2 Business Segments
RKLB Stock Jumps as Rocket Lab Debuts New Solar Cell for ******* e
#Services #Stock #laboratories
2 months ago
With their sights set on securing their fourth win of the tournament, Chivas are ready for another Apertura 2026 challenge. Guadalajara are already in the capital of San Luis Potosí, where they will visit Atlético de San Luis at Estadio Libertad Financiera in a Jornada 7 matchup.
Ahead of this game, Gabriel Milito and his coaching staff have selected the 22 players who make up the rojiblanca squad, with an important return to the Rebaño standing out and generating plenty of anticipation among Chivahermanos.
What are the changes to the squad?
Daniel Aguirre has been included in the squad and could make an appearance against the Potosinos.
Miguel Gómez experienced intense pain during one of the training sessions. After undergoing the corresponding imaging studies, it was confirmed that he has suffered a muscle injury. His return to competition will depend on his recovery.
#squad #return #estadio
Ahead of this game, Gabriel Milito and his coaching staff have selected the 22 players who make up the rojiblanca squad, with an important return to the Rebaño standing out and generating plenty of anticipation among Chivahermanos.
What are the changes to the squad?
Daniel Aguirre has been included in the squad and could make an appearance against the Potosinos.
Miguel Gómez experienced intense pain during one of the training sessions. After undergoing the corresponding imaging studies, it was confirmed that he has suffered a muscle injury. His return to competition will depend on his recovery.
#squad #return #estadio
2 months ago
Chances are, if you have watched a YouTube video, you have come across one where the creator is recording their experiences through a small, handheld camera. Usually, it is a GoPro (GPRO). And it is in the news now because prominent YouTuber and filmmaker Markiplier (also known as Mark Fischbach) has become the single largest shareholder of the company. Additionally, the company has now entered into a $285 million merger agreement with photonics company Starman Optical.
Aimed at expanding GoPro's reach in the AI and defense market, Starman CEO Charles Tebele said, "Advanced optics and imaging are essential to AI, national security, and the broader economy, yet much of the critical hardware supporting these technologies continues to be manufactured overseas. The combination of GoPro's world-class optical expertise and intellectual property with Starman's advanced transceiver capabilities and U.S. manufacturing platform creates a unique opportunity. Together, we intend to bring production of these critical components back to the United States."
Dear GameStop Stock Fans, Mark Your Calendars for September 8
Why **** ysts Think Sellas Life Sciences Stock Can Gain 150% From Here
Jensen Huang: Nvidia's Vera Rubin Platform Turns Electricity Into a $40 Billion Cash Machine
#advanced #platform #critical
Aimed at expanding GoPro's reach in the AI and defense market, Starman CEO Charles Tebele said, "Advanced optics and imaging are essential to AI, national security, and the broader economy, yet much of the critical hardware supporting these technologies continues to be manufactured overseas. The combination of GoPro's world-class optical expertise and intellectual property with Starman's advanced transceiver capabilities and U.S. manufacturing platform creates a unique opportunity. Together, we intend to bring production of these critical components back to the United States."
Dear GameStop Stock Fans, Mark Your Calendars for September 8
Why **** ysts Think Sellas Life Sciences Stock Can Gain 150% From Here
Jensen Huang: Nvidia's Vera Rubin Platform Turns Electricity Into a $40 Billion Cash Machine
#advanced #platform #critical
2 months ago
CHICAGO (AP) — The Chicago Cubs have shut down right-hander Ben Brown for the rest of the season so he can fully heal from a stress reaction in his neck that has sidelined him since mid-June.
The 26-year-old Brown is 4-2 with a 1.85 ERA in 20 games this season, including his final eight as a starter after Chicago's rotation was depleted by injuries. After shifting to a starting role, Brown was 3-1 with a 1.70 ERA.
The stress reaction flared after Brown tossed six innings and allowed two runs in a 16-2 win over Toronto on June 19 and he was placed on the IL. The same painful condition caused Brown to miss significant time in 2024.
Brown attempted to come back this season, but experienced discomfort during a throwing session on Aug. 25. That scuttled plans to send him on a minor-league rehab ****** ignment and led to additional medical consultation and imaging.
"This is a bone injury," manager Craig Counsell said before Thursday's game against Milwaukee at Wrigley Field. "There's a healing, but just not enough to allow the discomfort to go away. So we just need to spend more time healing.
#season #reaction #time #healing
The 26-year-old Brown is 4-2 with a 1.85 ERA in 20 games this season, including his final eight as a starter after Chicago's rotation was depleted by injuries. After shifting to a starting role, Brown was 3-1 with a 1.70 ERA.
The stress reaction flared after Brown tossed six innings and allowed two runs in a 16-2 win over Toronto on June 19 and he was placed on the IL. The same painful condition caused Brown to miss significant time in 2024.
Brown attempted to come back this season, but experienced discomfort during a throwing session on Aug. 25. That scuttled plans to send him on a minor-league rehab ****** ignment and led to additional medical consultation and imaging.
"This is a bone injury," manager Craig Counsell said before Thursday's game against Milwaukee at Wrigley Field. "There's a healing, but just not enough to allow the discomfort to go away. So we just need to spend more time healing.
#season #reaction #time #healing
2 months ago
CINCINNATI (AP) — San Diego Padres second baseman Luis Rengifo will undergo season-ending surgery for a torn ACL in his right knee.
The Padres announced Monday that imaging showed a full tear of the ACL. The injury had initially been diagnosed as a knee sprain.
Rengifo was injured in the seventh inning of a 7-6 loss to Tampa Bay on Saturday when he threw across his body toward home and fell to to the infield dirt. Rengifo needed ***** istance getting to his feet before he was driven off the field in a medical cart.
The play happened when two Tampa Bay players were near third base at the same time and Cedric Mullins broke for home. Rengifo was chasing Taylor Walls when he made the throw and immediately went down.
Rengifo started the season with the Milwaukee Brewers, who released him on June 23. He hit .205 in 57 games with the Brewers.
#brewers #knee #cincinnati #luis
The Padres announced Monday that imaging showed a full tear of the ACL. The injury had initially been diagnosed as a knee sprain.
Rengifo was injured in the seventh inning of a 7-6 loss to Tampa Bay on Saturday when he threw across his body toward home and fell to to the infield dirt. Rengifo needed ***** istance getting to his feet before he was driven off the field in a medical cart.
The play happened when two Tampa Bay players were near third base at the same time and Cedric Mullins broke for home. Rengifo was chasing Taylor Walls when he made the throw and immediately went down.
Rengifo started the season with the Milwaukee Brewers, who released him on June 23. He hit .205 in 57 games with the Brewers.
#brewers #knee #cincinnati #luis
2 months ago
CINCINNATI (AP) — San Diego Padres second baseman Luis Rengifo will undergo season-ending surgery for a torn ACL in his right knee.
The Padres announced Monday that imaging showed a full tear of the ACL. The injury had initially been diagnosed as a knee sprain.
Rengifo was injured in the seventh inning of a 7-6 loss to Tampa Bay on Saturday when he threw across his body toward home and fell to to the infield dirt. Rengifo needed ******* istance getting to his feet before he was driven off the field in a medical cart.
The play happened when two Tampa Bay players were near third base at the same time and Cedric Mullins broke for home. Rengifo was chasing Taylor Walls when he made the throw and immediately went down.
Rengifo started the season with the Milwaukee Brewers, who released him on June 23. He hit .205 in 57 games with the Brewers.
#diego
The Padres announced Monday that imaging showed a full tear of the ACL. The injury had initially been diagnosed as a knee sprain.
Rengifo was injured in the seventh inning of a 7-6 loss to Tampa Bay on Saturday when he threw across his body toward home and fell to to the infield dirt. Rengifo needed ******* istance getting to his feet before he was driven off the field in a medical cart.
The play happened when two Tampa Bay players were near third base at the same time and Cedric Mullins broke for home. Rengifo was chasing Taylor Walls when he made the throw and immediately went down.
Rengifo started the season with the Milwaukee Brewers, who released him on June 23. He hit .205 in 57 games with the Brewers.
#diego
2 months ago
NEW YORK – George Lombard Jr. exited Saturday night's second game of a day-night doubleheader due to right knee discomfort.
Following his second at-bat against the Red Sox, the Yankees' rookie shortstop was replaced defensively in the top of the fourth inning at Yankee Stadium.
Lombard was headed for imaging Saturday night at New York-Presbyterian Hospital, according to the Yankees.
The play in question occurred during Lombard's first at-bat, in Saturday night's second inning against Red Sox's right-hander Brayan Bello.
Lombard winced as he checked his swing on an inside pitch, which drew the attention of Yanks manager Aaron Boone and head athletic trainer Tim Lentych.
#lombard #saturday #second #night
Following his second at-bat against the Red Sox, the Yankees' rookie shortstop was replaced defensively in the top of the fourth inning at Yankee Stadium.
Lombard was headed for imaging Saturday night at New York-Presbyterian Hospital, according to the Yankees.
The play in question occurred during Lombard's first at-bat, in Saturday night's second inning against Red Sox's right-hander Brayan Bello.
Lombard winced as he checked his swing on an inside pitch, which drew the attention of Yanks manager Aaron Boone and head athletic trainer Tim Lentych.
#lombard #saturday #second #night
2 months ago
NEW YORK (AP) — New York Mets slugger Juan Soto was reinstated from the 10-day injured list on Saturday ahead of the team's game against the Houston Astros.
The five-time All-Star landed on the injured list last month for the second time this season after imaging revealed a grade 2 strain.
Soto had been nursing the nagging calf problem for about a week before he left a game against the Dodgers in discomfort. He walked twice against Los Angeles starter Roki Sasaki during a 4-2 loss at Citi Field before being replaced by pinch-hitter Jorge Polanco in the sixth inning with the score tied at 1.
Soto is hitting .283 with 21 homers, 52 RBIs and a .947 OPS in 84 games during his second season with the Mets.
The Mets also optioned infielder Eric Wagaman to Triple-A following Friday night's 3-1 loss to the Astros.
#soto
The five-time All-Star landed on the injured list last month for the second time this season after imaging revealed a grade 2 strain.
Soto had been nursing the nagging calf problem for about a week before he left a game against the Dodgers in discomfort. He walked twice against Los Angeles starter Roki Sasaki during a 4-2 loss at Citi Field before being replaced by pinch-hitter Jorge Polanco in the sixth inning with the score tied at 1.
Soto is hitting .283 with 21 homers, 52 RBIs and a .947 OPS in 84 games during his second season with the Mets.
The Mets also optioned infielder Eric Wagaman to Triple-A following Friday night's 3-1 loss to the Astros.
#soto
2 months ago
NEW YORK — The same Yankees saga has been playing out all season:
Every time one or two players are ready to come off the injured list, someone else gets hurt.
Manager Aaron Boone's Wednesday pre-game news conference included good and bad updates, then his post-game session ended with a big dose of ugly that had nothing to do with rookie shortstop George Lombard Jr.'s bobble for a fifth game in a row with an error.
Following the Yankees' 9-3 win over the Astros, Boone shared the imaging results for reliever Fernando Cruz, who went on the 15-day IL earlier in the day with right elbow discomfort.
Yankees -1.5 run line is listed at +128 on FanDuel for Thursday night's game against the Astros. Our complete FanDuel Sportsbook review will show you how to navigate through their app.
#york #aaron #wednesday
Every time one or two players are ready to come off the injured list, someone else gets hurt.
Manager Aaron Boone's Wednesday pre-game news conference included good and bad updates, then his post-game session ended with a big dose of ugly that had nothing to do with rookie shortstop George Lombard Jr.'s bobble for a fifth game in a row with an error.
Following the Yankees' 9-3 win over the Astros, Boone shared the imaging results for reliever Fernando Cruz, who went on the 15-day IL earlier in the day with right elbow discomfort.
Yankees -1.5 run line is listed at +128 on FanDuel for Thursday night's game against the Astros. Our complete FanDuel Sportsbook review will show you how to navigate through their app.
#york #aaron #wednesday
2 months ago
Tempus AI, Inc. (NASDAQ:TEM) rallied following a melanoma breakthrough reported by Moderna and Merck. The companies said their Phase 3 INTerpath-001 trial met its recurrence-free survival endpoint for the personalized cancer therapy intismeran autogene, also known as V940, combined with Keytruda. Detailed trial data remain pending. The read-through came from Personalis, which has supported the V940 clinical-development program since its inception. Tempus agreed in July to a pending acquisition of Personalis at a $1.5 billion enterprise value, net of Tempus's existing stake. The question for Tempus AI, Inc. (NASDAQ:TEM) is whether the result validates the acquisition or merely confirms that one Personalis platform is strategically relevant to personalized cancer therapy.
Personalis uses ImmunoID NeXT to sequence tumor information for personalized vaccine development. That technology is distinct from NeXT Personal, the company's tumor-informed molecular residual disease test and the central strategic target of the acquisition. For Tempus AI, Inc. (NASDAQ:TEM), the clinical result validates Personalis's sequencing capabilities without establishing the economics of either product.
Tempus AI, Inc. (NASDAQ:TEM) is acquiring a company that has supported the V940 program from its beginning. A successful Phase 3 endpoint could strengthen Personalis's credibility with biopharma customers and create additional sequencing opportunities as drugmakers pursue individualized therapies across more tumor types.
The acquisition also reaches beyond vaccine sequencing. Tempus AI, Inc. (NASDAQ:TEM) has commercialized NeXT Personal since 2023. The MRD test searches for small traces of circulating tumor DNA after treatment, helping clinicians monitor response and identify possible recurrence before it becomes visible through conventional imaging.
Tempus AI, Inc. (NASDAQ:TEM) reported 9,000 total MRD tests in the second quarter, up from 6,500 sequentially. Personalis generated finalized quarterly revenue of $22.357 million and delivered 10,384 clinical tests, with volume rising 33% sequentially. NeXT Personal also has Medicare coverage in three indications, giving the pending transaction a commercial foundation independent of V940.
#v940 #acquisition #tumor
Personalis uses ImmunoID NeXT to sequence tumor information for personalized vaccine development. That technology is distinct from NeXT Personal, the company's tumor-informed molecular residual disease test and the central strategic target of the acquisition. For Tempus AI, Inc. (NASDAQ:TEM), the clinical result validates Personalis's sequencing capabilities without establishing the economics of either product.
Tempus AI, Inc. (NASDAQ:TEM) is acquiring a company that has supported the V940 program from its beginning. A successful Phase 3 endpoint could strengthen Personalis's credibility with biopharma customers and create additional sequencing opportunities as drugmakers pursue individualized therapies across more tumor types.
The acquisition also reaches beyond vaccine sequencing. Tempus AI, Inc. (NASDAQ:TEM) has commercialized NeXT Personal since 2023. The MRD test searches for small traces of circulating tumor DNA after treatment, helping clinicians monitor response and identify possible recurrence before it becomes visible through conventional imaging.
Tempus AI, Inc. (NASDAQ:TEM) reported 9,000 total MRD tests in the second quarter, up from 6,500 sequentially. Personalis generated finalized quarterly revenue of $22.357 million and delivered 10,384 clinical tests, with volume rising 33% sequentially. NeXT Personal also has Medicare coverage in three indications, giving the pending transaction a commercial foundation independent of V940.
#v940 #acquisition #tumor
2 months ago
Xiaomi Corporation (OTC:XIACF) is no longer content to compete through hardware design and pricing alone. The Chinese smartphone maker has unveiled the Xring O3, which is the second generation of its proprietary handset processor, as it seeks greater control over the technology powering its devices.
The strategy could improve product differentiation and bolster Xiaomi's negotiating position with outside chip suppliers, all the while supporting its expansion into premium smartphones. However, the investment comes as rising component costs and weakening global handset demand are already pressuring the company's core business. Let's dive deeper into it.
Developing processors internally could give Xiaomi greater control over several features that influence the smartphone experience. A system-on-chip integrates computing, graphics, artificial intelligence processing, and imaging functions, allowing the company to optimize important capabilities around its own hardware and software. Xiaomi launched its first proprietary smartphone processor, the Xring O1, in 2025. During its latest earnings call, the company said ******* ulative shipments of O1-powered smartphones, tablets, and watches had surpassed one million units. Although Reuters' sources estimated that only approximately 150,000 of those shipments were smartphones, the broader total shows Xiaomi has already deployed the technology across multiple product categories.
The O3 could also support Xiaomi's push into more expensive devices. According to two people familiar with the plans, TSMC will manufacture the processor using its 3-nanometre technology. One source said the chip is expected to power Xiaomi's next flagship foldable phone, with shipments targeted at between 200,000 and 300,000 units. Foldables offer Xiaomi an opportunity to compete more directly in a premium category currently dominated in China by Huawei. Huawei shipped 1.6 million foldable smartphones in China during the second quarter, accounting for 68% of the market, according to data cited by Reuters.
The company's ambitions also extend beyond smartphones. Reuters reported that Xiaomi contracted TSMC to produce the Xring O100, a 6-nanometre neural-processing chip designed to support its MiMo artificial-intelligence model on consumer devices, and the Xring D100, a 3-nanometre autonomous-driving processor. Xiaomi said both chips have completed development and are scheduled for deployment next year. Together, these projects show that Xiaomi is extending its chip-development strategy beyond smartphones into AI-enabled consumer devices and autonomous driving.
#shipments
The strategy could improve product differentiation and bolster Xiaomi's negotiating position with outside chip suppliers, all the while supporting its expansion into premium smartphones. However, the investment comes as rising component costs and weakening global handset demand are already pressuring the company's core business. Let's dive deeper into it.
Developing processors internally could give Xiaomi greater control over several features that influence the smartphone experience. A system-on-chip integrates computing, graphics, artificial intelligence processing, and imaging functions, allowing the company to optimize important capabilities around its own hardware and software. Xiaomi launched its first proprietary smartphone processor, the Xring O1, in 2025. During its latest earnings call, the company said ******* ulative shipments of O1-powered smartphones, tablets, and watches had surpassed one million units. Although Reuters' sources estimated that only approximately 150,000 of those shipments were smartphones, the broader total shows Xiaomi has already deployed the technology across multiple product categories.
The O3 could also support Xiaomi's push into more expensive devices. According to two people familiar with the plans, TSMC will manufacture the processor using its 3-nanometre technology. One source said the chip is expected to power Xiaomi's next flagship foldable phone, with shipments targeted at between 200,000 and 300,000 units. Foldables offer Xiaomi an opportunity to compete more directly in a premium category currently dominated in China by Huawei. Huawei shipped 1.6 million foldable smartphones in China during the second quarter, accounting for 68% of the market, according to data cited by Reuters.
The company's ambitions also extend beyond smartphones. Reuters reported that Xiaomi contracted TSMC to produce the Xring O100, a 6-nanometre neural-processing chip designed to support its MiMo artificial-intelligence model on consumer devices, and the Xring D100, a 3-nanometre autonomous-driving processor. Xiaomi said both chips have completed development and are scheduled for deployment next year. Together, these projects show that Xiaomi is extending its chip-development strategy beyond smartphones into AI-enabled consumer devices and autonomous driving.
#shipments
2 months ago
On August 10, 2026, Teledyne Technologies Incorporated (NYSE:TDY) agreed to acquire Varex Imaging for $18.90 a share in an all-cash deal valued at about $1.1 billion. It sent Varex Imaging Corporation (NASDAQ:VREX) shares up nearly 50% before the opening bell.
Teledyne is paying a large premium for a smaller X-ray components maker just as Varex posted a genuine earnings beat of its own. Is Teledyne buying real, complementary technology at a fair long-term price, or paying a steep premium right as Varex's turnaround was already starting to work?
CEO Robert Mehrabian said the companies serve similar customers with "uniquely complementary" products and minimal overlap. He noted Teledyne Technologies Incorporated (NYSE:TDY) doesn't make X-ray detectors suited for high-radiation environments like oncology the way Varex does. Both boards unanimously approved the deal, which is expected to close in early 2027.
Nearly a 50% one-day jump in Varex's stock shows the market sees this as a rich price for Teledyne to pay. Integrating Varex's X-ray business, which serves medical, security, and industrial markets, adds real complexity to Teledyne Technologies Incorporated (NYSE:TDY)'s existing operations.
CEO Sunny Sanyal said the deal marks "an exciting new chapter," giving Varex Imaging Corporation (NASDAQ:VREX) access to Teledyne's resources to accelerate use of its imaging technology. Varex also posted third-quarter adjusted profit of 31 cents a share, 10 cents ahead of **** yst estimates, after recovering tariff-related costs and generating $21 million in operating cash flow. It shows the business was already improving before the deal was announced.
#NASDAQ
Teledyne is paying a large premium for a smaller X-ray components maker just as Varex posted a genuine earnings beat of its own. Is Teledyne buying real, complementary technology at a fair long-term price, or paying a steep premium right as Varex's turnaround was already starting to work?
CEO Robert Mehrabian said the companies serve similar customers with "uniquely complementary" products and minimal overlap. He noted Teledyne Technologies Incorporated (NYSE:TDY) doesn't make X-ray detectors suited for high-radiation environments like oncology the way Varex does. Both boards unanimously approved the deal, which is expected to close in early 2027.
Nearly a 50% one-day jump in Varex's stock shows the market sees this as a rich price for Teledyne to pay. Integrating Varex's X-ray business, which serves medical, security, and industrial markets, adds real complexity to Teledyne Technologies Incorporated (NYSE:TDY)'s existing operations.
CEO Sunny Sanyal said the deal marks "an exciting new chapter," giving Varex Imaging Corporation (NASDAQ:VREX) access to Teledyne's resources to accelerate use of its imaging technology. Varex also posted third-quarter adjusted profit of 31 cents a share, 10 cents ahead of **** yst estimates, after recovering tariff-related costs and generating $21 million in operating cash flow. It shows the business was already improving before the deal was announced.
#NASDAQ
2 months ago
Eiffage has secured contracts worth a combined €132m ($153.9m) for two hospital projects in France, via its subsidiaries Eiffage Énergie Systèmes and Eiffage Construction.
The bulk of the total, close to €109m, covers the first phase of the Convergences project at Angers University Hospital, where a new medical-technical platform is planned.
Eiffage Construction will handle the main structural works, the building envelope and finishing works under the macro-works package.
Eiffage Énergie Systèmes takes the ventilation and electrical packages, covering power and low-voltage systems.
The Angers building will span 38,400m² over five storeys and house emergency services, operating theatres, imaging and adult critical care units.
#hospital #nergie #france
The bulk of the total, close to €109m, covers the first phase of the Convergences project at Angers University Hospital, where a new medical-technical platform is planned.
Eiffage Construction will handle the main structural works, the building envelope and finishing works under the macro-works package.
Eiffage Énergie Systèmes takes the ventilation and electrical packages, covering power and low-voltage systems.
The Angers building will span 38,400m² over five storeys and house emergency services, operating theatres, imaging and adult critical care units.
#hospital #nergie #france
2 months ago
Revvity, Inc. (RVTY), headquartered in Waltham, Massachusetts, is a leading provider of health sciences solutions, technologies, and diagnostic services. Valued at $13.9 billion by market cap, the company focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and other areas.
Shares of this leading research and diagnostic firm have outperformed the broader market over the past year. RVTY has gained 39.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.5%. In 2026, RVTY's stock rose 28.9%, surpassing the SPX's 12.1% rise on a YTD basis.
Soros Fund Management Opened a New Position in Nebius During Q2. What This Means for NBIS Stock.
Nvidia Earnings, Jackson Hole and Other Key Things to Watch this Week
Ahead of Nvidia Earnings, Here's What Barchart Data Says Comes Next for NVDA Stock
#Stock #rvty #diagnostic #revvity
Shares of this leading research and diagnostic firm have outperformed the broader market over the past year. RVTY has gained 39.1% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.5%. In 2026, RVTY's stock rose 28.9%, surpassing the SPX's 12.1% rise on a YTD basis.
Soros Fund Management Opened a New Position in Nebius During Q2. What This Means for NBIS Stock.
Nvidia Earnings, Jackson Hole and Other Key Things to Watch this Week
Ahead of Nvidia Earnings, Here's What Barchart Data Says Comes Next for NVDA Stock
#Stock #rvty #diagnostic #revvity
2 months ago
Rumer Willis is opening up about how her dad Bruce Willis' dementia diagnosis has impacted her life.
The actress, 38, revealed that she is partnering with Function – a health membership that offers more than 160 advanced lab tests, imaging and specialized **** sments – as her father's diagnosis has led her to take a closer look at her own health.
"I really miss my dad. I miss a different version of who he was," Rumer Willis said in an Instagram video posted Monday, Aug. 24. "There are some days that are just so hard. I try to prioritize being present with where he's at now. The truth is, to be strong is learning to deal with both things at the same time."
In February 2023, Bruce Willis' family revealed that his earlier aphasia diagnosis progressed to frontotemporal dementia, or FTD, which impacts the parts of the brain generally **** ociated with personality, behavior and language, according to Mayo Clinic. The "Die Hard" star, 71, had stepped away from acting the year prior due to health issues.
Rumer Willis, the eldest daughter of Demi Moore and Bruce Willis, said that "because of my family history," she decided to undergo genetic testing for APOE, a gene **** ociated with Alzheimer's risk, noting that it is "obviously kind of important."
#willis #rumer #diagnosis #hard
The actress, 38, revealed that she is partnering with Function – a health membership that offers more than 160 advanced lab tests, imaging and specialized **** sments – as her father's diagnosis has led her to take a closer look at her own health.
"I really miss my dad. I miss a different version of who he was," Rumer Willis said in an Instagram video posted Monday, Aug. 24. "There are some days that are just so hard. I try to prioritize being present with where he's at now. The truth is, to be strong is learning to deal with both things at the same time."
In February 2023, Bruce Willis' family revealed that his earlier aphasia diagnosis progressed to frontotemporal dementia, or FTD, which impacts the parts of the brain generally **** ociated with personality, behavior and language, according to Mayo Clinic. The "Die Hard" star, 71, had stepped away from acting the year prior due to health issues.
Rumer Willis, the eldest daughter of Demi Moore and Bruce Willis, said that "because of my family history," she decided to undergo genetic testing for APOE, a gene **** ociated with Alzheimer's risk, noting that it is "obviously kind of important."
#willis #rumer #diagnosis #hard
2 months ago
MLB.com | Bryan Hoch: Cody Bellinger is slated to return from the IL today. The outfielder had a short rehab stint at Scranton/Wilkes-Barre as he recovered from a Grade 2 left hamstring strain that's kept him off the field since late July. "I've been wanting to get back for a while," Bellinger said. "You always want to be realistic, and for me, I want to come back and stay. You don't want to make anything worse. I'm itching to get back, but I've got to continue to play it safe and make sure I'm 100 percent ready." In his second year with New York, Bellinger was an All-Star this season and figures to fortify an outfield that's also been without Aaron Judge in right.
New York Post | Andrew Crane: Giancarlo Stanton strained his left calf earlier this week, calling into question whether he'll be able to return this season, Aaron Boone revealed Saturday. The DH was working back from multiple strains to his right calf when he fell while running the bases, leading to a moderate strain in his left. "We're at a point in the calendar where it gets challenging," said Boone, acknowledging the reality that Stanton's return this season is in jeopardy. Big G has appeared in only 24 games this season, adding to the struggles to stay on the field that have plagued his Yankees tenure.
(As a related aside, you should read Josh's editorial, "Giancarlo Stanton and outrunning the sunset." It's quite good.)
MLB.com | Bryan Hoch: In other injury news, Ryan Weathers exited his start Saturday in the fourth inning with left forearm discomfort. He's scheduled for imaging on Sunday. In his first season in the Bronx, the left-hander had been a strong contributor to the rotation, including during a recent stretch in which he posted a 1.94 ERA in his last seven starts. For more on Weathers' departure and some musings on short- and long-term implications, check out Andrew's breaking news post.
The Athletic | Brendan Kuty: ($) There was a world where Bellinger's return could have cost Spencer Jones his roster spot. The rookie outfielder has been playing well of late, though, going 12-for-41 with two homers and four stolen bases in his last 12 games."(He's) certainly proved that he can play up here," said Boone. "I think there's a lot more in the tank for him to continue to go and learn, but he's showing the ability to do that, and that's been really encouraging."
#back #bryan #i 've
New York Post | Andrew Crane: Giancarlo Stanton strained his left calf earlier this week, calling into question whether he'll be able to return this season, Aaron Boone revealed Saturday. The DH was working back from multiple strains to his right calf when he fell while running the bases, leading to a moderate strain in his left. "We're at a point in the calendar where it gets challenging," said Boone, acknowledging the reality that Stanton's return this season is in jeopardy. Big G has appeared in only 24 games this season, adding to the struggles to stay on the field that have plagued his Yankees tenure.
(As a related aside, you should read Josh's editorial, "Giancarlo Stanton and outrunning the sunset." It's quite good.)
MLB.com | Bryan Hoch: In other injury news, Ryan Weathers exited his start Saturday in the fourth inning with left forearm discomfort. He's scheduled for imaging on Sunday. In his first season in the Bronx, the left-hander had been a strong contributor to the rotation, including during a recent stretch in which he posted a 1.94 ERA in his last seven starts. For more on Weathers' departure and some musings on short- and long-term implications, check out Andrew's breaking news post.
The Athletic | Brendan Kuty: ($) There was a world where Bellinger's return could have cost Spencer Jones his roster spot. The rookie outfielder has been playing well of late, though, going 12-for-41 with two homers and four stolen bases in his last 12 games."(He's) certainly proved that he can play up here," said Boone. "I think there's a lot more in the tank for him to continue to go and learn, but he's showing the ability to do that, and that's been really encouraging."
#back #bryan #i 've
2 months ago
In an unexpected development, Milwaukee Brewers pitcher Brandon Woodruff will not need surgery to repair the anterior capsule in his right shoulder.
Woodruff, 33, expected to undergo surgery this month, which would have been the second procedure performed on his shoulder in three years. Yet after undergoing new four-week imaging scans and consulting with orthopedic surgeon Dr. Keith Meister, surgery was not recommended, according to the Milwaukee Journal Sentinel's Curt Hogg.
Instead, Woodruff will begin a five-week throwing progression and continue plyometric work as part of his rehabilitation.
Despite the encouraging news. the nine-year veteran is still unlikely to return for the Brewers' upcoming postseason run. Brewers manager Pat Murphy is hoping there's a chance, but acknowledged the uphill climb Woodruff faces.
"I think there's a low possibility, but I think there's a possibility," Murphy told MLB.com's Casey Drottar.
#murphy
Woodruff, 33, expected to undergo surgery this month, which would have been the second procedure performed on his shoulder in three years. Yet after undergoing new four-week imaging scans and consulting with orthopedic surgeon Dr. Keith Meister, surgery was not recommended, according to the Milwaukee Journal Sentinel's Curt Hogg.
Instead, Woodruff will begin a five-week throwing progression and continue plyometric work as part of his rehabilitation.
Despite the encouraging news. the nine-year veteran is still unlikely to return for the Brewers' upcoming postseason run. Brewers manager Pat Murphy is hoping there's a chance, but acknowledged the uphill climb Woodruff faces.
"I think there's a low possibility, but I think there's a possibility," Murphy told MLB.com's Casey Drottar.
#murphy
2 months ago
The New York Yankees announced that starting pitcher Ryan Weathers was pulled from Saturday's start against the Toronto Blue Jays due to "forearm discomfort."
The announcement added that the veteran southpaw would be undergoing imaging to determine the severity of the injury.
Weathers made it through only 3 1/3 innings. He threw 72 pitches and allowed two earned runs on eight hits. Weathers didn't issue any walks and struck out three.
The 26-year-old is in his first season with the Yankees. He has made 25 starts this year and has tallied a 5-7 record with a 3.60 ERA. The southpaw has struck out 143 batters in 137 1/3 innings of work.
Weathers is the latest Yankee to be banged up. It was announced on Saturday that Giancarlo Stanton, who is recovering from a right calf strain, suffered a new injury to his left calf during a fall while running.
#southpaw #injury #year #calf
The announcement added that the veteran southpaw would be undergoing imaging to determine the severity of the injury.
Weathers made it through only 3 1/3 innings. He threw 72 pitches and allowed two earned runs on eight hits. Weathers didn't issue any walks and struck out three.
The 26-year-old is in his first season with the Yankees. He has made 25 starts this year and has tallied a 5-7 record with a 3.60 ERA. The southpaw has struck out 143 batters in 137 1/3 innings of work.
Weathers is the latest Yankee to be banged up. It was announced on Saturday that Giancarlo Stanton, who is recovering from a right calf strain, suffered a new injury to his left calf during a fall while running.
#southpaw #injury #year #calf
2 months ago
Yankees starter Ryan Weathers exited Saturday's game at Yankee Stadium with a left forearm injury.
After delivering a fourth-inning pitch to the Toronto Blue Jays' Myles Straw, the left-handed Weathers grimaced and moved to the back of the pitching mound. He was soon replaced by reliever Yerry de los Santos.
In 3.1 innings Saturday, Weathers yielded two runs on eight hits and no walks, with three strikeouts in a 72-pitch effort.
According to the Yankees, Weathers exited with forearm discomfort and was headed for imaging Saturday.
Last week, the Yankees put fellow lefty starter Max Fried back on the 15-day injury list due to a second bone bruise to his pitching elbow this season, though Fried is hopeful of returning by early September.
#weathers #left
After delivering a fourth-inning pitch to the Toronto Blue Jays' Myles Straw, the left-handed Weathers grimaced and moved to the back of the pitching mound. He was soon replaced by reliever Yerry de los Santos.
In 3.1 innings Saturday, Weathers yielded two runs on eight hits and no walks, with three strikeouts in a 72-pitch effort.
According to the Yankees, Weathers exited with forearm discomfort and was headed for imaging Saturday.
Last week, the Yankees put fellow lefty starter Max Fried back on the 15-day injury list due to a second bone bruise to his pitching elbow this season, though Fried is hopeful of returning by early September.
#weathers #left
2 months ago
It looks as if Jake Bobo's fourth season with the Seattle Seahawks is already over.
The fan favorite wide receiver and special teams contributor suffered what was described as a "bad-looking leg injury" during Friday's joint practice with the Tennessee ****** ans in Nashville. He was carted off after awkwardly landing on a catch attempt, and barring some very favorable imaging, that will be his last action on the field this year.
"Our heart goes out to Jake Bobo," Mike Macdonald said after practice. "Seems like it's going to be a serious knee, we're going to get it imaged, but early returns—looks like it's a long-term injury. So that's unfortunate."
Bobo re-signed with the Seahawks on a two-year deal after matching the Jacksonville Jaguars' restricted free agent offer sheet. He's functioned as the fourth or fifth option at wide receiver, doing a lot of the dirty work as a blocker and in kick and punt return coverage. His NFC Championship touchdown against the Los Angeles Rams was his only score all season and it helped Seattle get to the Super Bowl.
In all likelihood, Bobo would've played the Sunday preseason game against the ****** ans, having played the first half of last week's game against the Dallas Cowboys. Unfortunately, it appears as if the next time we see Bobo will be 2027.
#fourth #season #wide
The fan favorite wide receiver and special teams contributor suffered what was described as a "bad-looking leg injury" during Friday's joint practice with the Tennessee ****** ans in Nashville. He was carted off after awkwardly landing on a catch attempt, and barring some very favorable imaging, that will be his last action on the field this year.
"Our heart goes out to Jake Bobo," Mike Macdonald said after practice. "Seems like it's going to be a serious knee, we're going to get it imaged, but early returns—looks like it's a long-term injury. So that's unfortunate."
Bobo re-signed with the Seahawks on a two-year deal after matching the Jacksonville Jaguars' restricted free agent offer sheet. He's functioned as the fourth or fifth option at wide receiver, doing a lot of the dirty work as a blocker and in kick and punt return coverage. His NFC Championship touchdown against the Los Angeles Rams was his only score all season and it helped Seattle get to the Super Bowl.
In all likelihood, Bobo would've played the Sunday preseason game against the ****** ans, having played the first half of last week's game against the Dallas Cowboys. Unfortunately, it appears as if the next time we see Bobo will be 2027.
#fourth #season #wide
2 months ago
The San Francisco 49ers couldn't quite get out of SoFi Stadium without any injuries.
Keeping players healthy is the top priority in the preseason and head coach Kyle Shanahan had a trio of injury updates immediately following his team's 41-17 romp over the Los Angeles Chargers on Thursday.
Cornerback Renardo Green left the game early with a hamstring issue. Shanahan said the team doesn't know the extent of the damage just yet.
"We'll have to get some imaging on that tomorrow to see if he pulled it," Shanahan said.
The other key injury came to reserve offensive lineman Austen Pleasants who went down with a knee injury in the third quarter. Shanahan told reporters it isn't an ACL tear, but they'll find out exactly what the injury is after imaging Friday.
#imaging #francisco #keeping #kyle
Keeping players healthy is the top priority in the preseason and head coach Kyle Shanahan had a trio of injury updates immediately following his team's 41-17 romp over the Los Angeles Chargers on Thursday.
Cornerback Renardo Green left the game early with a hamstring issue. Shanahan said the team doesn't know the extent of the damage just yet.
"We'll have to get some imaging on that tomorrow to see if he pulled it," Shanahan said.
The other key injury came to reserve offensive lineman Austen Pleasants who went down with a knee injury in the third quarter. Shanahan told reporters it isn't an ACL tear, but they'll find out exactly what the injury is after imaging Friday.
#imaging #francisco #keeping #kyle
2 months ago
The San Francisco 49ers offensive line depth took a hit Thursday night when offensive lineman Austen Pleasants went down with an apparent knee injury midway through the third quarter.
Pleasants was pushed backward while engaged in a block and then reached for his right knee. He was holding his right knee while on the ground being attended to by trainers.
The veteran offensive lineman quickly entered the medical tent on the sidelines and was almost immediately ruled out. Being immediately ruled out instead of getting listed as questionable isn't a good sign for the nature of the injury. We should get more information from head coach Kyle Shanahan after the game, but the team may also wait to get imaging on Pleasants before making any decisions on him.
Pleasants on Thursday entered the mix for left guard. Rookie carver Willis started the game, but it was Pleasants who got the first opportunities when Willis went to the sideline. Willis was first in line after Pleasants went out.
More 49ers: Struggling 49ers WR may have earned a roster spot with this highlight play
#pleasants #went #thursday #lineman
Pleasants was pushed backward while engaged in a block and then reached for his right knee. He was holding his right knee while on the ground being attended to by trainers.
The veteran offensive lineman quickly entered the medical tent on the sidelines and was almost immediately ruled out. Being immediately ruled out instead of getting listed as questionable isn't a good sign for the nature of the injury. We should get more information from head coach Kyle Shanahan after the game, but the team may also wait to get imaging on Pleasants before making any decisions on him.
Pleasants on Thursday entered the mix for left guard. Rookie carver Willis started the game, but it was Pleasants who got the first opportunities when Willis went to the sideline. Willis was first in line after Pleasants went out.
More 49ers: Struggling 49ers WR may have earned a roster spot with this highlight play
#pleasants #went #thursday #lineman
2 months ago
Dave Roberts addresses Edwin Diaz concern after another rough outing originally appeared on The Sporting News. Add The Sporting News as a Preferred Source by clicking here.
Edwin Diaz's difficult first season with the Los Angeles Dodgers has taken another troubling turn.
The Dodgers placed their closer on the injured list Tuesday because of inflammation on the right side of his neck, adding another setback to a season in which Diaz has struggled to find the dominant form that once made him one of baseball's premier relievers.
Diaz returned to Los Angeles on Tuesday and is expected to undergo imaging to determine the severity of the injury.
"It's kind of something that he felt [Monday] night," Dodgers manager Dave Roberts said. "We don't know if it's something that has been there, call it a week or whatever, but it kind of showed its head last night. So we're going to kind of address it."
#kind #edwin #tuesday
Edwin Diaz's difficult first season with the Los Angeles Dodgers has taken another troubling turn.
The Dodgers placed their closer on the injured list Tuesday because of inflammation on the right side of his neck, adding another setback to a season in which Diaz has struggled to find the dominant form that once made him one of baseball's premier relievers.
Diaz returned to Los Angeles on Tuesday and is expected to undergo imaging to determine the severity of the injury.
"It's kind of something that he felt [Monday] night," Dodgers manager Dave Roberts said. "We don't know if it's something that has been there, call it a week or whatever, but it kind of showed its head last night. So we're going to kind of address it."
#kind #edwin #tuesday
